MTOR and neoplasm: We treated mice with the mTOR inhibitor AZD8055 (20mg kg−1) and found that inhibition of mTORC1 and mTORC2 significantly inhibited tumor growth (4.72 ± 1.19, n=3 mean ± SD, P<0.001) compared with Vehicle treated mice (Fig. 2A, B).